Harmonex

Harmonex Neuroscience is a specialized clinical research organization and site based in Dothan, Alabama, that focuses on conducting Phase II through Phase IV clinical trials for central nervous system (CNS) disorders. The company provides comprehensive clinical trial services, including patient recruitment, study management, and data collection for pharmaceutical and biotechnology sponsors. Their expertise spans a wide range of psychiatric and neurological conditions, such as ADHD, depression, Alzheimer's disease, and schizophrenia. By maintaining a dedicated facility and a database of qualified participants, Harmonex facilitates the development of new therapeutic interventions in the mental health and neuroscience sectors.